- Home
- VNCE vs NRBO Comparison
VNCE vs NRBO Comparison
Compare VNCE & NRBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNCE
- NRBO
- Stock Information
- Founded
- VNCE 2002
- NRBO N/A
- Country
- VNCE United States
- NRBO United States
- Employees
- VNCE N/A
- NRBO N/A
- Industry
- VNCE Clothing/Shoe/Accessory Stores
- NRBO Biotechnology: Pharmaceutical Preparations
- Sector
- VNCE Consumer Discretionary
- NRBO Health Care
- Exchange
- VNCE Nasdaq
- NRBO Nasdaq
- Market Cap
- VNCE 25.2M
- NRBO 27.9M
- IPO Year
- VNCE 2013
- NRBO N/A
- Fundamental
- Price
- VNCE $1.75
- NRBO $2.46
- Analyst Decision
- VNCE Strong Buy
- NRBO Strong Buy
- Analyst Count
- VNCE 2
- NRBO 1
- Target Price
- VNCE $3.00
- NRBO $10.00
- AVG Volume (30 Days)
- VNCE 9.2K
- NRBO 34.1K
- Earning Date
- VNCE 12-04-2024
- NRBO 11-07-2024
- Dividend Yield
- VNCE N/A
- NRBO N/A
- EPS Growth
- VNCE N/A
- NRBO N/A
- EPS
- VNCE 0.10
- NRBO N/A
- Revenue
- VNCE $292,727,000.00
- NRBO N/A
- Revenue This Year
- VNCE $0.48
- NRBO N/A
- Revenue Next Year
- VNCE $5.47
- NRBO N/A
- P/E Ratio
- VNCE $18.42
- NRBO N/A
- Revenue Growth
- VNCE N/A
- NRBO N/A
- 52 Week Low
- VNCE $1.15
- NRBO $2.08
- 52 Week High
- VNCE $4.73
- NRBO $6.75
- Technical
- Relative Strength Index (RSI)
- VNCE 45.54
- NRBO 39.90
- Support Level
- VNCE $1.81
- NRBO $2.37
- Resistance Level
- VNCE $2.01
- NRBO $2.99
- Average True Range (ATR)
- VNCE 0.10
- NRBO 0.30
- MACD
- VNCE -0.01
- NRBO 0.00
- Stochastic Oscillator
- VNCE 20.00
- NRBO 22.22
About VNCE Vince Holding Corp.
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.
About NRBO NeuroBo Pharmaceuticals Inc.
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.